3411 e11. 592, H18. 3393 for Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral is a medical classification as listed by WHO. 0, R11. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. 22. 3393 for bilateral; Use E11. Ambulatory infusion pump is an electrical or battery operated device, which is used to deliver solutions containing a parenteral drug under pressure at a regulated flow rate. E11. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 1 C56. E11. Toggle Menu. 3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,. 8 C79. Treatment of infected foot wounds accounts for up to one-quarter of all inpatient hospital admissions for people with 2023 MIPS Measure #127: Diabetes Mellitus: Diabetic Foot and Ankle Care, Ulcer Prevention – Evaluation of Footwear Pegcetacoplan injection (Syfovre) is a synthetic peptide that binds to complement protein C3 and its activation fragment C3b which then regulates the binding of C3 and the sequence of downstream effectors of the activated complement protein. 3399 With severe nonproliferative retinopathy, with macular edema E11. 3392 E11. 3391 - E11. If you believe that the Claims Administrator/Insurer has failed to provide these services or discriminated in another way on the basis of race, color, national origin, age, disability, or sex, you can file a grievance with: Civil Rights Coordinator, P. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. 3393 X E11. The sleeve gastrectomy (SG) is a surgical procedure performed in either an open or laparoscopic manner. 1 result found: ICD-10-CM Diagnosis Code E11. 22. 339 may differ. Long Description: Type 2 diabetes mellitus with. 3493 e11. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. 591, H18. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 1 of the Program Integrity Manual, to remove all coding from LCDs and incorporate into related Billing and Coding Articles. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. This is the American ICD-10-CM version of E11. It is the goal of these diagnostic imaging tests to discriminate among patients with normal intraocular pressures (IOP) who have glaucoma, patients with elevated IOP who have. Remove: E09. 3411 ☐ E11. E11. This was a coding algorithm development and comparison study; no patient selection or analysis of patient data was performed. 3412 e10. Diabetic retinopathy in patients with or without DME; or. 3393 2) Patients with diabetes should be screened annually for chronic kidney disease. The 2024 edition of ICD-10-CM E10 became effective on October 1, 2023. 3393 E10. 331. 3393 [convert to ICD-9-CM] Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral. Denominator Exception: Documentation of patient reason(s) for not communicating the findings of the dilated macular or fundus exam to the physician or other qualified health care professional managing the ongoing care of theVersion 5. People with diabetes are at increased risk of serious health complications including vision loss, heart disease, stroke, kidney failure, amputation of toes, feet or legs, and premature death. The following code(s) above E11. 33 - other international versions of ICD-10 E11. " A pale or swollen optic nerve documented by a recent examination. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 10 - R11. 3392 E11. Original JH ICD-9 Source L32731, Frequency of Laboratory Tests. Diagnostic codes are the first step in the DRG mapping process. MTMS are to be completed by a MTMS pharmacist provider face-to-face and will include a complete assessment. 3399* Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. 3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,. Denominator Criteria (Eligible Cases): Patients aged ≥ 18 years on date of encounterA disorder of the orbit, potentially affecting the visual field (e. 3312 ☐ E11. 3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,. 3399 With severe nonproliferative retinopathy, with macular edema E11. E11. 117. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. Initial screening should commence: 5 years after the diagnosis of type 1 diabetes; (Evidence Grade = A) or from diagnosis of type 2 E11. 3393 Diabetes with Severe NPDR with Macular Edema Type 2 Type 1 ☐ E11. Diabetic retinopathy is progressive damage to the small blood vessels in the retina that may result in loss of vision. E11. Federal statute and subsequent Medicare regulations regarding provision and payment for medical services are lengthy. Short description: Type 2 diab with moderate nonp rtnop with macular edema, bi The 2024 edition of ICD-10-CM E11. 3511 e11. 34 Type 2 diabetes mellitus with severe nonproli. 3399 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without. 3519 e10. Version 7. 33 became effective on October 1, 2023. 3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,. 3392 e11. 81 C56. E11. Clinicians who indicate modifier 55, postoperative management. 2 C56. 3393 Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy without macular edema, bilateral. 3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. an estimated $327 billion: $237 billion in direct medical costs and $90 billion in reduced productivity. 3313 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema E11. Other Contractor Local Coverage Determinations. 3393* Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. Quality ID #19 (NQF 0089): Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care – National Quality Strategy Domain: Communication and Care Coordination – Meaningful Measure Area: Transfer of Health Information and Interoperability 2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS)E11. 311 is a billable diagnosis code used to specify a medical diagnosis of type 2 diabetes mellitus with unspecified diabetic retinopathy with macular edema. E13. an estimated $245 billion: $176 billion in direct medical costs and $69 billion in reduced productivity. Coverage Indications, Limitations, and/or Medical Necessity. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 3519 E11. This is a 34 percent increase from the estimated $245 billion spent on diabetes in 2012 (American Diabetes Association, 2018). Assuming the patient's primary diagnostic code is E11. 3413 bilateral2022 Clinical Quality Measure Flow for Quality ID #117 (NQF 0055): Diagnosis: measurement period:Global Edits to Measure Specifications: • Added Meaningful Measures Category in Titles • Updated Language for Information Regarding Non-Billable CodingE11. Short description: Diabetes with moderate nonp rtnop without macular edema, bi The 2024 edition of ICD-10-CM E08. 3393 [convert to ICD-9-CM] Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral. For electronic claims, Loop/Element 2400 SV101-7 must be completed for Not Otherwise Classified (NOC) codes. 339 is based on the following Tabular structure: Chapter 4: Endocrine,. Scanning computerized ophthalmic diagnostic imaging (SCODI) allows for early detection of glaucomatous damage to the nerve fiber layer or optic nerve of the eye. 3311 became effective on October 1, 2023. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024. This measure is to be submitted a minimum of once per performance period for all patients with diabetes mellitus seen during the performance period. E11. 3412 E11. ICD-10-CM Diagnosis Code E11. 9 D34 D35. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. See full list on icdlist. 5 and F84. No substantive changes were made to the active LCD. 3132, h35. Measure #118 (NQF 0066): Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic*Signifies that this CPT Category I code is a non-covered service under the Medicare Part B Physician Fee Schedule (PFS). The following services are considered to be components of routine foot care, regardless of the provider rendering the service: Cutting or removal of corns and calluses; Clipping, trimming, or debridement of nails, including debridement of mycotic nails; Shaving, paring, cutting or removal of keratoma, tyloma, and heloma;E11. E11. E11. 3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,. This measure. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. N/A. Instructions: This measure is intended to reflect the quality of services provided for the patients receiving cataract surgery. 3292 E11. 22* Type 2 diabetes mellitus with diabetic chronic kidney disease. The supplier is responsible for ensuring that there is an appropriate. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. 3493 Key for Table 1: blue numerals (5th position) indicate whether nPdR is mild, moderate, or severe; green numerals (6th posi- This revision is due to the Annual ICD-10 Code Update and is effective on 10/1/20. 3293 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 3539Abstract: Visual field testing detects defects in the field of vision, testing the function of the retina, optic nerve and optic pathways. Without macular edema and other specified diabetes. h35. Diabetes outpatient self-management and training service is a program which educates individuals in self-monitoring of blood glucose, diet, exercise, and insulin management. A cataract is an opacity or cloudiness in the lens of the eye (s), blocking the passage of light through the lens, sometimes resulting in impaired vision. 23, H44. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 3120, h35. 3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,. Federal statute and subsequent Medicare regulations regarding provision and payment for medical services are lengthy. A cataract is an opacity or cloudiness in the lens of the eye (s), blocking the passage of light through the lens, sometimes resulting in impaired vision. All rights reserved. 3311 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. They are not repeated. The following services are considered to be components of routine foot care, regardless of the provider rendering the service: Cutting or removal of corns and calluses; Clipping, trimming, or debridement of nails, including debridement of mycotic nails; Shaving, paring, cutting or removal of keratoma, tyloma, and heloma;The sleeve gastrectomy (SG) is a surgical procedure performed in either an open or laparoscopic manner. History/Background and/or General Information. 25, E11. It is small, portable, and designed to be carried by the member. A distinct numeric result is required for numerator compliance. 3412 Type 2 diabetes mellitus with severe non-proliferative diabetic retinopathy with macular edema, left. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 1. *Signifies that this CPT Category I code is a non-covered service under the Medicare Part B Physician Fee Schedule (PFS). E11. 3393* Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 329, E11. E11. 3499 With proliferative retinopathy, with macular edema E11. 2P) OR . 3593 became effective on October 1, 2023. Scanning computerized ophthalmic diagnostic imaging (SCODI) allows for early detection of glaucomatous damage to the nerve fiber layer or optic nerve of the eye. This is a 34 percent increase from the estimated $245 billion spent on diabetes in 2012 (American Diabetes Association, 2018). 3392 left eye E11. 3591-E11. 3412 Limited proprietary coding is contained in the measure specifications for convenience. E11. 339. 33 contain annotation back-referencesE11. 311 is a billable diagnosis code used to specify a medical diagnosis of type 2 diabetes mellitus with unspecified diabetic retinopathy with macular edema. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. 3391 ☐ E11. 89 C79. 37X9. 3511-E11. 9 and E11. 3393. Degenerative Disorders of Globe H44. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. 3499 e10. This is the American ICD-10-CM version of E10 - other international versions of ICD-10 E10 may differ. E11. 3399 With severe non-proliferative retinopathy, with macular edema E11. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 3412 Type 2 diabetes mellitus with severe non-proliferative diabetic retinopathy with macular edema, left. CMS Measure ID: #1 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: No High Priority: Yes NQS Domain: Effective Clinical Care Measure Age: > 2 years Instructions. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. - QPP. an estimated $327 billion: $237 billion in direct medical costs and $90 billion in reduced productivity. 3393 Type 2 diabetes mellitus. 3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,. Please note the clinical documentation must clearly show that. E11. 3393: Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, right eye - Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 3591- E13. Type 2 diabetes mellitus with stable proliferative diabetic retinopathy. 3311 E11. Toxic retinopathies, including those caused by intraocular metallic foreign bodies, Vigabatrin. 3491 e11. Instructions. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024. Eligible clinicians who have given a prescription to the patient for or whose patient is currently taking a combination medication therapy, which contains either an angiotensin convertingThe 2024 edition of ICD-10-CM E11. The listed denominator criteria are used to identify the intended patient population. The surgery involves excision of the lateral aspect of the stomach, leaving a much reduced, tubular stomach. E13. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema E11. 0 CPT only copyright 2022 American Medical Association. November 2020 Page 1 of 11. 3591, e11. E11. E13. 3413 X E11. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition. It is the leading cause of blindness in adults between 20-74 years of age. 3391 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema right eye E11. Performance Not Met: Most recent hemoglobin A1c (HbA1c) level greater than or equal to 7. Other Contractor Local Coverage Determinations. 3592, e11. Myopic Choroidal Neovascularization (mCNV); or. 3311 - E11. Formal visual field tests are generally performed using automated perimetry, i. The redetermination process may be utilized for consideration of services performed outside of the reasonable and necessary requirements in this LCD. Quality ID #117 (NQF 0055): Diabetes: Eye Exam - Healthmonix. 3533 e10. E11. The following code(s) above E11. 3393 became effective on October 1, 2023. ICD-10 code E11. The . 12 Clavulanate Timentin Antibiotic X X X X X Clindamycin Cleocin Antibiotic X X X X X Dantrolene Dantrium Antidote X X X X Cost invoice with NDC required with claim. 3511 e10. 3412 E11. Pay lesser of billed charges and cost invoice. 41, E11. Coverage Indications, Limitations, and/or Medical Necessity. This measure is to be submitted a minimum of once per performance period for patients with diabetes mellitus seen during the performance period. 3393 bilateral E11. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. They are not repeated. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 3411 E11. 3313 became effective on October 1, 2023. E11. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. 3299 With moderate nonproliferative retinopathy, with macular edema E11. At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This sensor operates using signal and low reference. Short description: Type 2 diab with mod nonp. E13. Approximately 9 percent of American adults currently have CKD (NKF, 2019), and it is projected that by 2030 approximately 17 percent of Americans aged 30 years and older will have CKD (Saran et al. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 593) CPT Codes Corneal graft procedure (CPT: 65756 with modifier RT, LT) How to Report the Measure This is a 34 percent increase from the estimated $245 billion spent on diabetes in 2012 (American Diabetes Association, 2018). Unexplained visual loss which may be described as "trouble seeing or vision going in and out. Cataract development occurs in 60% of adults 65 years of age or greater. 3313 X E11. Avacincaptad pegol intravitreal solution (Izervay) may be considered medically necessary for the treatment of individuals with the following condition: Geographic atrophy (GA) secondary to nonexudative (dry) AMD; and. E11. E11. At this time 21 st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. 3491 E11. Description Prescription Description. The Part A Ophthalmology: Extended Ophthalmoscopy and Fundus Photography LCD L34571 is being retired effective 02/19/2016 as this LCD is being incorporated into LCD L33467. SCODI also allows for differentiation and diagnosis of other disorders of the optic nerve, as well as monitoring for progressive optic neuropathy and response to treatment in a number of neuro-ophthalmologic conditions. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. 3522 e10. 3412 Methods. 3391 ☐ E11. This revision has a retroactive effective date of 2/26/2018. 638, E13. All neoplasms, whether functionally. 3391-E11. This. E11. 3413 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edemaE11. 22. No substantive changes were made to the active LCD. 2, F84. 3511. Women-only measures Screening and care documentation guidelines Code(s) Cervical Cancer Screening (CCS) 21- to 64-year-old women Evidence of pap exam within last three yearsCoverage Indications, Limitations, and/or Medical Necessity. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 3391 E11. “Frequency of Laboratory Tests,” TrailBlazer Health Enterprises LCD, (00400) L20354, (00900) L14227. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. R2. All rights reserved. 3492 e10. 99504, 99509, e0100, e0105, e0130, e0135, e0140, e0141, e0143, e0144, e0147, e0148, e0149, e0163, e0165, e0167, e0168, e0170, e0171, e0250, e0251, e0255, e0256,E11. 3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,. This will allow the postoperative period to occur within the reporting year. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 3492 E11. 3412* A type 1 excludes note is a pure excludes. Diabetes outpatient self-management and training service is a program which educates individuals in self-monitoring of blood glucose, diet, exercise, and insulin management. 3413 X E11. 3391 E11. 3521 e10. E11. E11. The goal of this Local Coverage Determination (LCD) is to ensure that evidence-based medicine addressing the risks of acute and chronic complications of diabetes mellitus (DM) are integrated into the delivery of home health (HH) services for Medicare beneficiaries with Type II DM. E11. • Updated Rationale and Clinical Recommendation Statements • Added Denominator Coding, CPT: 99211, 99386, 99387, 99396, 99397 Quality ID #117: Diabetes: Eye Exam Start Patients aged ≥ 18 years on date of encounter Diagnosis for diabetes as listed in Denominator* Patient encounter during the performance E0787. Diabetic retinopathy is progressive damage to the small blood vessels in the retina that may result in loss of vision. 22, H44. Original JH ICD-9 Source L32731, Frequency of Laboratory Tests. 3393 X E11. E11. OCT, especially SCODI, produces high resolution, cross-sectional tomographic images of ocular structures and is used for the evaluation of the optic nerve head, nerve fiber layer, and retina. CMS 131v11. 10 may differ. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. Inability to. 3411 e11. Hospice services provided to patient any time during the measurement period. 3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,. 3311 ☐E10. E11. Without macular edema and other specified diabetes. 3391 - E11. Include only procedures performed through November 30 of the reporting period. 3393 E10. 3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema,. 37X2. 1 result found: ICD-10-CM Diagnosis Code E11. 3313 E10. 3412* Ranibizumab (Lucentis) may be considered medically necessary for the treatment of individuals with ANY ONE of the following conditions: Diabetic macular edema (DME); or. 3399 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without. 3293 became effective on October 1, 2023. 3552, e11. E11. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. E11. Under Associated Contractor Numbers added 11201, 11301, 11401, and 11501. Hemoglobin A1c (HbA1c) refers to the major component of hemoglobin A1. Pay lesser of billed charges and cost invoice. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 3559, e11. 3511 E11. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. 3313 is a billable diagnosis code used to specify type 2 diab with moderate nonp rtnop with macular edema, bi. 3391 - E11. Payment may be made for only one pump for administering the medications; and. A cataract is an opacity or cloudiness in the lens of the eye (s), blocking the passage of light through the lens, sometimes resulting in impaired vision. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. Performance Met: Hemoglobin A1c level was not performed during the measurement period (12 months) (3046F with 8P) OR. E11. 3121, h35. 3393. 3513 X E11. Geographic atrophy (GA) is a late stage of dry age-related macular degeneration (AMD). E11. Clinicians who indicate modifier 55, postoperative management. 3393 - Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral The above description is abbreviated. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. 331 Internal Medical Policy Committee 3-23-2022 Annual Review-no changes in criteria. 3411 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye E11. 3393 [convert to ICD-9-CM] Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral. 3393 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral E11. 3413: Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with. Proliferative Diabetic Retinopathy Other) The following codes are effective beginning October 1, 2016. 3393 Type 2 diabetes mellitus with moderate non-proliferative diabetic retinopathy without macular edema, bilateral; E11. Contractor is not responsible for the continued viability of websites listed. 3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathyE11. Diabetes is a long lasting disease marked by high blood glucose levels, resulting from the body's inability toScanning computerized ophthalmic diagnostic imaging (SCODI) allows for early detection of glaucomatous damage to the nerve fiber layer or optic nerve of the eye. Full field electroretinogram (ERG) is used to detect loss of retinal function or distinguish between retinal and optic nerve lesions. When performed laparoscopically, the term laparoscopic sleeve gastrectomy (LSG) is used. 3130, h35. Include only procedures performed through November 30 of the reporting period. E11. 341, E10. The Part A Ophthalmology: Extended Ophthalmoscopy and Fundus Photography LCD L34571 is being retired effective 02/19/2016 as this LCD is being incorporated into LCD L33467. No substantive changes were made to the active LCD. Currently, CGM system sensors can be used three (3)-90 days before replacement. E13. E11. A cataract is an opacity or cloudiness in the lens of the eye (s), blocking the passage of light through the lens, sometimes resulting in impaired vision. 3391 E11. Electroretinography used to diagnose loss of retinal function or distinguish between retinal lesions and optic nerve lesions may be considered medically necessary for ANY ONE of the following indications (This is not an all-inclusive list):. 37X3, E11. It should not be used for HIPAA. There are multiple factors associated with cataract development. 3493 X E11. 10*, E11. 3 D09.